Technology | November 01, 2011

TruFlight Select PET/CT Offers Economical Time-of-Flight Technology

Philips TruFlight Select is its first economical positron emission tomography/computed tomography (PET/CT) system equipped premium time-of-flight (TOF) technology, Astonish TF.  Competitive systems with similar performance can cost up to $500,000 more than the TruFlight Select PET/CT. 

Traditionally, TOF technology on PET/CT systems is only accessible to facilities that can afford high-end imaging systems.  Philips believes that all clinicians should have access to TOF because the technology can help improve lung and liver lesion detectability. TOF technology is designed to enhance image quality by reducing image artifacts, providing high sensitivity and up to 30 percent improved contrast when compared to non-TOF systems. The resulting images help clinicians better detect and locate lesions to increase diagnostic confidence and preserve healthy tissue during treatment. The TruFlight Select can be used for multiple purposes, including routine oncology imaging, diagnostic CT and the incorporation of PET radiation therapy planning.

Key Benefits/Features:

  • Cost-saving benefits from low system costs and the ability to utilize short lived isotopes
  • Time-of-Flight provides exceptional image quality
  • Enhanced speed, productivity and throughput with the Extended Brilliance Workspace for Nuclear medicine

For more information: www.healthcare.philips.com

Related Content

Biodex Unveils Atomlab 500 Dose Calibrator and Wipe Test Counter
Technology | Nuclear Imaging | October 19, 2017
Biodex Medical Systems announced the full release of the Atomlab Dose Calibrator and Wipe Test Counter to the market...
ASNC and ASE Team Up to Expand ImageGuide Registry
News | Cardiovascular Ultrasound | October 12, 2017
The American Society of Nuclear Cardiology (ASNC) and the American Society of Echocardiography (ASE) jointly announced...
MR Solutions Showcases Multimodality MRI Solutions on Two Continents
News | Magnetic Resonance Imaging (MRI) | October 11, 2017
October 11, 2017 — MR Solutions took their cryogen-free preclinical multimodality...
Majority of Recurrent Prostate Cancer Patients' Treatment Plan Changed Following Fluciclovine 18F PET/CT
News | Prostate Cancer | October 04, 2017
Blue Earth Diagnostics recently announced the results of a pre-planned interim analysis from an investigational...
News | Business | September 19, 2017
September 19, 2017 — Invicro LLC, a provider of imaging services and software for research and drug development, anno
ScImage and Invia Partnership Announced
News | PACS | September 19, 2017
ScImage Inc. and Invia Imaging Solutions recently announced formation of a joint partnership at the American Society of...
Toshiba Highlights Latest CT Advancements at RSNA 2017
News | Computed Tomography (CT) | September 18, 2017
Toshiba Medical announced that it will display several new enhancements to its existing computed tomography (CT)...
Philips Launches CardioMD IV Cardiac SPECT Solution at ASNC 2017
Technology | SPECT Imaging | September 15, 2017
September 15, 2017 — Philips highlighted its newest solution for...
Double Targeting Ligands to Identify and Treat Prostate Cancer

The mice were imaged with small-animal PET/CT using 124I-RPS-027 (7.4 MBq [200 μCi]). Credit: JM Kelly et al., Department of Radiology, Weill Cornell Medicine, New York, NY

News | Prostate Cancer | September 14, 2017
Researchers have demonstrated a new, effective way to precisely identify and localize prostate cancer tumors while...
Blue Earth Diagnostics Announcing Results of FALCON PET/CT Trial at ASTRO 2017
News | PET-CT | September 13, 2017
September 13, 2017 — Blue Earth Diagnostics announced the upcoming oral presentation of initial results from the FALC
Overlay Init